Factbox: Key upcoming clinical trials of hydroxychloroquine, touted by Trump, for COVID-19

Credit: Reuters- Published on May 26, 2020
The World Health Organization has suspended testing the malaria drug hydroxychloroquine in COVID-19 patients due to potential safety risks but other studies testing the medicine are continuing.
Advertisement

Video credit: Wochit
Published on May 26, 2020 -  00:38
World Health Organization Halts Trials Of Hydroxychloroquine
The World Health Organization announced they are temporarily suspending clinical trials of hydroxychloroquine. The controversial drug has been used as an experimental coronavirus treatment for the past several months. Now, amid mounting safety concerns experts are ending all clinical trials involving the medication. According to Gizmodo, testing for hydroxychloroquine has been halted pending a safety assessment. A recent study has linked the drug to an increased risk of death and heart conditions among COVID-19 patients. U.S. President Donald Trump announced last week that he has been taking the drug for nearly 2 weeks as a preventative. There is no data that supports Hydroxychloroquine is a preventive medication for COVID-19.

You are here

Related videos from verified sources

WHO halts malaria drug in COVID-19 trials 01:05
Credit: Reuters Studio - Published 21 hours ago 


Return To Sender? Millions Of Hydroxychloroquine Pills Locked In Limbo 00:36
Credit: Wochit - Published 2 weeks ago 


Trump Criticizes FDA Over Hydroxychloroquine Decision 00:32
Credit: Wochit Tech - Published 3 weeks ago